VALLERINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 6.734
EU - Europa 2.868
AS - Asia 1.985
SA - Sud America 258
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 1
Totale 11.891
Nazione #
US - Stati Uniti d'America 6.675
GB - Regno Unito 971
SG - Singapore 614
CN - Cina 610
SE - Svezia 451
IT - Italia 407
HK - Hong Kong 305
DE - Germania 270
BR - Brasile 209
RU - Federazione Russa 174
FI - Finlandia 144
VN - Vietnam 136
UA - Ucraina 123
TR - Turchia 97
FR - Francia 87
IN - India 62
BG - Bulgaria 49
CA - Canada 34
ID - Indonesia 34
CZ - Repubblica Ceca 31
BE - Belgio 29
KR - Corea 28
ES - Italia 23
JP - Giappone 18
NL - Olanda 18
AR - Argentina 17
IE - Irlanda 15
LT - Lituania 15
PL - Polonia 15
ZA - Sudafrica 13
AT - Austria 11
BD - Bangladesh 11
IR - Iran 10
EU - Europa 9
MY - Malesia 9
BZ - Belize 8
IQ - Iraq 8
MX - Messico 8
CL - Cile 7
MA - Marocco 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
VE - Venezuela 5
CO - Colombia 4
KG - Kirghizistan 4
PA - Panama 4
CH - Svizzera 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
PK - Pakistan 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
CY - Cipro 2
LB - Libano 2
MK - Macedonia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AU - Australia 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
ZM - Zambia 1
Totale 11.891
Città #
Fairfield 801
Ashburn 705
Southend 686
Santa Clara 546
Woodbridge 486
Chandler 432
Singapore 395
Houston 365
Ann Arbor 344
Hong Kong 301
Seattle 289
Nyköping 249
Wilmington 235
Cambridge 224
Jacksonville 218
Dearborn 211
Modena 128
London 121
New York 121
Hefei 116
Beijing 107
Los Angeles 100
Helsinki 83
Munich 77
Chicago 64
Fremont 63
San Diego 54
Sofia 48
Princeton 46
Bremen 45
Eugene 44
Ho Chi Minh City 43
Izmir 43
Hanoi 35
Moscow 34
Des Moines 32
Buffalo 30
Council Bluffs 29
Brussels 27
Boardman 26
Dallas 26
Seoul 26
Jakarta 24
Milan 24
Salt Lake City 24
Shanghai 24
San Jose 23
Redwood City 22
The Dalles 22
Turku 20
Atlanta 18
São Paulo 18
Orem 16
Tokyo 16
Brooklyn 15
Toronto 15
Columbus 14
Dublin 14
Montreal 14
Bologna 13
Denver 12
Elk Grove Village 12
Las Vegas 12
Stockholm 12
Chennai 11
Kunming 11
Paris 11
Tampa 11
Warsaw 11
Washington 11
Da Nang 10
Dong Ket 10
Phoenix 10
San Francisco 10
Albuquerque 9
Brno 9
Guangzhou 9
Poplar 9
Belize City 8
Boston 8
Frankfurt am Main 8
Kilburn 8
Johannesburg 7
Lancaster 7
Nanjing 7
Rio de Janeiro 7
Rome 7
Sterling 7
Vienna 7
Wuhan 7
Bangalore 6
Chiswick 6
Detroit 6
Jinan 6
Leawood 6
Norwalk 6
Amsterdam 5
Bengaluru 5
Brasília 5
Changsha 5
Totale 8.725
Nome #
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 412
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 365
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 344
B cells and herpesviruses: a model of lymphoproliferation 341
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 334
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 327
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 320
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 310
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 302
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 299
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 299
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 297
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 288
Mucorales-specific T cells in patients with hematologic malignancies 287
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 286
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 285
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 283
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 281
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 279
Parvoviruses in blood donors and transplant patients, Italy 277
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 266
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 260
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 260
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 258
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 258
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 251
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 248
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 244
Diagnosis of aspergillosis: Role of proteomics 243
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 242
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 239
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 235
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 234
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 233
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 231
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 223
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 221
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 219
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 216
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 208
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 207
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 206
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 180
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 176
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 163
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 100
Totale 12.037
Categoria #
all - tutte 44.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021773 0 0 0 0 0 94 78 177 65 184 94 81
2021/20221.124 44 138 143 61 27 41 61 57 96 99 225 132
2022/20231.284 191 180 80 129 197 151 47 108 100 9 51 41
2023/2024778 19 26 63 60 156 100 79 139 14 10 53 59
2024/20252.024 84 32 51 154 363 296 145 124 235 86 157 297
2025/20261.969 315 138 263 343 616 294 0 0 0 0 0 0
Totale 12.037